Pulmonary Veno-Occlusive Disease (disorder)
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
1
|
0.720 |
None |
1.000 |
5 |
1
|
2003 |
2016 |
Idiopathic pulmonary arterial hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
776
|
24
|
0.700 |
None |
0.978 |
185 |
4
|
2000 |
2020 |
Pulmonary Hypertension, Primary, 1
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
9
|
323
|
0.700 |
moderate |
1.000 |
57 |
308
|
2000 |
2018 |
Familial primary pulmonary hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
30
|
2
|
0.700 |
None |
1.000 |
48 |
2
|
1997 |
2019 |
Idiopathic pulmonary hypertension
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
161
|
5
|
0.600 |
None |
1.000 |
43 |
|
2000 |
2019 |
Pulmonary arterial hypertension
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
413
|
70
|
0.500 |
None |
0.927 |
55 |
49
|
2002 |
2020 |
PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
8
|
3
|
0.430 |
None |
1.000 |
3 |
2
|
2003 |
2016 |
Familial pulmonary arterial hypertension
|
disease |
|
Disease or Syndrome
|
12
|
1
|
0.400 |
None |
1.000 |
21 |
1
|
2005 |
2018 |
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
3
|
0.400 |
None |
1.000 |
2 |
3
|
2002 |
2014 |
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
1
|
0.400 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
PULMONARY VENOOCCLUSIVE DISEASE 1
|
disease |
|
Finding
|
1
|
4
|
0.400 |
limited |
|
0 |
4
|
|
|
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.370 |
None |
1.000 |
16 |
|
2001 |
2013 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.330 |
None |
1.000 |
4 |
|
2007 |
2015 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.330 |
None |
1.000 |
4 |
|
2007 |
2015 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.310 |
None |
1.000 |
2 |
|
2003 |
2013 |
Hyperandrogenism
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
108
|
24
|
0.310 |
None |
1.000 |
1 |
|
2012 |
2012 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
2-oxo-hept-3-ene-1,7-dioate hydratase activity
|
phenotype |
|
Molecular Function
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Pulmonary Hypertension, Primary, Fenfluramine-Associated
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Pulmonary arterial hypertension induced by drug
|
disease |
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.200 |
None |
1.000 |
40 |
1
|
2002 |
2020 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
2000 |
2000 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Right Ventricular Hypertrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
160
|
6
|
0.120 |
None |
1.000 |
2 |
1
|
2014 |
2019 |